No Detail Found!

Neurochemical and behavioral profiles of l-(l-naphthyl) piperazine in rats

Author(s)
Farhat Batool Department of Biochemistry, Neurochemistry and Biochemical Neuropharmacology Research Unit, University of Karachi Pakistan
Sonia Siddiqui Department of Biochemistry, Neurochemistry and Biochemical Neuropharmacology Research Unit, University of Karachi Pakistan
Darakhshan J. Haleem Department of Biochemistry, Neurochemistry and Biochemical Neuropharmacology Research Unit, University of Karachi Pakistan
Abstract
A dose-response study was performed to monitor neurochemical and behavioral effects of 1-(1-naphthyl) piperazine (1-NP) in rats. Intraperitoneal (i.p.) injections of 1-NP at doses of 5,10 and 15mg/kg increased ambulation in familiar as well as novel environment in a dose-dependent manner. Open arm exploration in an elevated plus maze decreased. Plasma levels of tryptophan increased significantly only at doses of 10 and 15mg/kg but brain tryptophan levels remained unaltered at the doses used. Brain levels of 5-hydroxyindoleacetic acid (5-HIAA) and 5-HIAA: 5-hydroxytryptamine (5-HT) ratio decreased but, 5-HT;serotonin concentration remained unaltered. The concentrations of noradrenaline (NA) increased in a dose-dependent manner. Dopamine (DA) levels decreased following the administration of 1-NP at doses of 5,10 and 15mg/kg. The concentration of dihydroxyphenylacetic acid (DOPAC) was not effected at doses of 5 and 10mg/kg and increased at doses of 15mg/kg. The levels of homovaniliic acid (HVA) were not effected. NA metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) significantly increased only at 5mg/kg of 1-NP and decreased at high doses of (10mg/kg and 15mg/kg) of the drug. It was concluded that post-synaptic 5-HT-1A receptor activation by 1-NP increases the extracellular NA level in the brain, which may be the cause of the increase of the locomotor activity. Neurochemical and behavioral effects of the drug are also discussed in relation to a potential therapeutic profile.
Publication Details
Page(s) 50-56
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 11, Issue: 1, Year: 2001

Request the full text from PASTIC

Keywords
Piperazines. Serotinin agonists. Maze learning. Norepinephrine. Behavioral medicine. Neurochemistry.
References
Murasaki M,Miura S. .1992 .The futureof 5-HT-1A receptor agonists. (Arylpiperazinederivatives). Prog NeuropsychopharmacoiBioiPsych, 16 : 6833-45.
. .Serotoninand anxiety:a reviewof currentresearchand clinicalimplicationsJ. CPSP\^^\ 9, (8) : 384-93.
McKearney JW .1989 .Serotonin-anatgonisteffectsof 1- (1-naphthylp)iperazineon operantbehaviorofsquirrel monkeys. NeuropharmacoiOgy, 28 : 817-21.
.1995 .BrileyM. In vitro and in vivo activityof 1-(1- naphthyl)piperazinaetterminal5-HT autoreceptorisn guina pig brain. Naunyn-Schmiedeberg's Arch Pharma, 351 : 377-84.
Hanson HM . .. Psychopharmacoiogy^lT, 55 : 27-33.
Simansky KJ,Schechter LE .1988 .Properties of some 1- arylpiperazineass antagonistsofstereotypedbehaviors mediatedby centralserotonergic receptors in rodents. JPharma Exp Ther, 247 : 1073-81.
Lucki I . .Differentialctionsofserotonin antagonistsin two behavioralmodelsof sero-. , : .
.1996 .Roleofhippocampa5l-HT-1A receptorson elevatedplus maze explorationaftera singlerestraintexperience. BehavBrainBes, 77 : 215-8.
. .Adaptationoffemale ratstostress:shifttomalepatternby inhibitionofcorticosteronesynthesis. , 458 : 339-47.
Haleem DJ .1996 .. BatoolF. Regionallyspecificeffectsof diazepamon brainserotoninmetabolis min rats:sustainedeffecftollowingrepeatedadministrationL.ifeSci, 59(15) : PL239-PL46.
Ortman R. .1985 .The 5-HT syndrome and thedrug discrimination paradigm in rats: Applicationin behavioral studies on thecentral5-HT system. Pharmacopsychiatry, 18 : 198-201.
Lyon RA .1986 .5-HT-1 and 5-HT-2 binding characteristicsof some quipazineanaloguesJ. MedChem, 29 : 2375-80.
Wedenberg ML .1989 .AlheniusS. Effectof8-OHDPAT on motor activityin therat. Pharma Biochem Behav, 32 : 797-800.
Marcou M,Dourish CT,Curzon G . .Single administrationof5-HT-1A agonistsdecreases5-HT-1A presynaptic,butnot postsynapticreceptor-mediated response: relationshipto antidepressant-likaection.. , : .
Lucki I,Ward HR,Frazer A . .Effecotfm-CPP andTFMPP on locomotoractivityJ. PharmaExp TherV&&\, 249 : 155-64.
Green AR,Guy AP,Gardner OR .1984 .The behavioraelffects of RU-24969, a suggested5-HT-1 receptoragonistin rodentsand theeffecton thebehaviorof treatment withantidepressantsN. europharmacology, 23 : 655-61.
Lowe JA,Seegar TF,Howard HR,Seymour PA,Heyn JH .1991 .-Naphthylpiperazindeerivativesas potentialatypicalanti-psychoticagents. J Med Chem, 34 : 1860-66.
Fernandez AG,Palacios JM .1996 .Effectsof 5-HT-4 receptorantagonistosn ratbehaviorin theelevatedplus-mazetest. EurJPharma, 309 : 219-22.
.1993 .-HT drugs in animalmodels ofanxiety. Psychopharmacology, 109 : 338-45.
.1996 .-Hydroxytryptamine-interactindgrugs in animalmodels of anxietydisorders: More than30 yearsofresearch. JPharma Exp Ther, 65 : 319-95.
.1993 .-HT drugs in animalmodels ofanxiety. Psychopharmacology, 112 : 13-21.
.1986 .Substitutepdhenylpiperazineass serotonin agonists: structuraldeterminantsof potency and interactionwith receptor subtypes. Psychopharma Bull, 22(3) : 825-8.
.1988 .Evidencethatm-CPP may have behavioraelffectmsediatedby central5-HT-1C receptors. BrJPharma, 94 : 137-47.
Cohen ML .1983 .FullerRW. Antagonismof vascularserotonin receptorsby m-chlorophenylpiperazinaend mtrifluoromethylpiperazLinifeS. ci, 32 : 711-8.
. .- HT uptakeblocker,citalopramo,n thesensitivityo,f5- HT autoreceptorsE: lectrophysiologicastludiesin the ratbrain. Naunyn-Schmiedeberg'sArch/%W771986;, 333 : 342-8.
Hamon M,Adrien J .1988 .Alterationsof centralserotonin and dopamine turnoverin ratstreatedwith ipsapironeand other5- HT-1A agonistswithpotentiaalnxiolyticproperties. J Pharma Exp Ther, 246 : 745-52.
Sharp T,Hjorth S,Grahame-Smith DG .1989 .Pharmacologicalcharacterizationof 8-OH-DPATinduced inhibitionofrathippocampal5-HT releasein vivo as measuredby microdialysis. BrJPharma, 98 : 989-97.
.1986 .-HT-1Aselectivedrugs on the 5-HT behavioralsyndrome. PharmaBiochem Behav, 24 : 1513-19.
Yocca FD .1990 .Neurochemistryand neurophysiologyof buspirone and gepirone interactionsat presynaptic and postsynaptic5-HT-1A receptors. Psychopharmacology, 10(3) : 68-125.
.1988 .-HT-1A receptoragonist,8- OH-DPAT, preferentiallayctivatescellbody 5-HT autoreceptorsin theratbrain in vivo. Naunyn-Schmiedeberg'sArch Pharma, 338 : 463-71.
VanderMaelen CP,Wilderman RC,Pate­r son LA .1986 .Inhibitionof serotonergicdorsalrapheneurons by systemicand iontophoreticadministrationof buspirone,a non-benzodiazepineanxiolyticdrug. EurJ Pharma, 129 : 123-30.
.1988 .Region-selective effectbsy 8-OH-DPAT on braindopaminesynthesisin vivo. Neurochemlnt, 13 : 80.
.1989 .Effectsof buspirone and its metabolite1-(2-pyrimidinyl) piperazine, on brain monoaminesand theirmetaboliteins rats. JPharma Exp Ther, 248 : 50-6.
Suzuki M .1995 .MatsudaT, Asano S, SomboonthumP, Takuma ofm-CPP and TFMPP in animalmodelsare opposed K, Baba A. Increase of noradrenalinereleasein the by 5-HT-1C receptorantagonistsE. urJPharma 1989; 164: hypothalamuosffreelymoving ratby postsynaptic5- 445-54. HT-1A receptoractivationB. rJPharma, 115 : 703-11.
Mason NR,Snoddy HD,Perry KW .1986 .-(1-Naphthylp)iperazine,acentralserotoninagonist. PesCommun Chem Path Pharma, 51 : 37-45.
Snoddy HD,Mason NR .1978 .m-trifluoromethylphenpyiple)razine on 3H-serotonin binding to membranesfrom ratbrain in vitro. EurJPharma, 52 : 11-6.
Suwabe A,Kubota M,Niwa M,Kobayashi K,Kanba S. Effecotfa5-HT- K .2000 .1A receptoragonist,fiesinoxan,on the extracellulnaorradrenalinelevelin thehippocampus and on thelocomotoractivityof rats. Brain Bes, 858(2) : 393-401.
Soderpalm B,Lundin B,Hjorth S B,withanxiolyticdrugs VI .1989 .ing of drugs interactingwith serotonin receptor subtypes. JPharma Exp Ther, 250 : 809-17.
0

Citations

0

Downloads

86

Views